|3Jun 8, 4:29 PM ET

REJUVEL BIO-SCIENCES, INC. 3

3 · REJUVEL BIO-SCIENCES, INC. · Filed Jun 8, 2017

Insider Transaction Report

Form 3
Period: 2017-01-19
PAVLIK JOSEPH
DirectorCEO
Holdings
  • SERIES C PREFERRED

    7,000,000
  • SERIES A PREFERRED

    1,500,000

Documents

1 file
  • 3
    pavlik-form3_052417apg.xmlPrimary

    OWNERSHIP DOCUMENT